ADIPOQ and cancer: Alterations have been detected in the levels of cytokines (e.g., adiponectin and ~11-fold increase in IL-6), as well as their tissue expression (e.g., five-fold increase in IL-6 in the subcutaneous AT (sAT)) in cachectic vs. weight-stable cancer patients [116].